Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary gold toxicity.

T F Morley, H J Komansky, R A Adelizzi

    European Journal of Respiratory Diseases
    |November 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    A patient developed lung complications from sodium aurothiomalate treatment for rheumatoid arthritis. Prednisone therapy successfully resolved these severe respiratory issues.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Editor's Mail.

    Postgraduate medicine·2016
    Same author

    COX-1 and COX-2 in health and disease.

    The Journal of the American Osteopathic Association·2000
    Same author

    Nebulized lidocaine in the treatment of refractory tussive syncope.

    The Journal of the American Osteopathic Association·1998
    Same author

    Noninvasive positive pressure ventilation: what is its role in treating acute respiratory failure?

    Postgraduate medicine·1996
    Same author

    Bronchiolitis obliterans organizing pneumonia in an AIDS patient.

    The European respiratory journal·1995
    Same author

    Clinical implications of NSAID pharmacokinetics: special populations, special considerations.

    The Journal of the American Osteopathic Association·1994
    Same journal

    Microbiological studies of tracheostomy site wounds.

    European journal of respiratory diseases·1987
    Same journal

    The effect of a peptide aldehyde reversible inhibitor of elastase on a human leucocyte elastase-induced model of emphysema in the hamster.

    European journal of respiratory diseases·1987
    Same journal

    Procoagulant activities in human alveolar macrophages.

    European journal of respiratory diseases·1987
    Same journal

    Occurrence of breathing problems induced by cold climate in asthmatics--a questionnaire survey.

    European journal of respiratory diseases·1987
    Same journal

    Non-invasive diagnosis of pulmonary hypertension in chronic obstructive pulmonary disease. Comparison of ECG, radiological measurements, echocardiography and myocardial scintigraphy.

    European journal of respiratory diseases·1987
    Same journal

    The effect of cigarette withdrawal on asthmatics who smoke.

    European journal of respiratory diseases·1987
    See all related articles

    Area of Science:

    • Rheumatology
    • Pulmonology
    • Pharmacology

    Background:

    • Rheumatoid arthritis is a chronic autoimmune disease.
    • Sodium aurothiomalate is a gold salt therapy used for rheumatoid arthritis.
    • Drug-induced lung injury is a potential complication of gold salt therapy.

    Observation:

    • A 52-year-old female presented with fever, cough, and dyspnea after 8 weeks of sodium aurothiomalate treatment.
    • The patient exhibited severe hypoxemia and bilateral pulmonary infiltrates on imaging.
    • These symptoms suggest a significant pulmonary reaction to the medication.

    Findings:

    • The clinical presentation was consistent with drug-induced pneumonitis.
    • Hypoxemia and pulmonary infiltrates indicated severe lung involvement.

    Related Experiment Videos

  • The patient's condition necessitated intervention beyond the initial treatment.

    • Implications:

    • This case highlights the importance of monitoring for pulmonary complications during gold salt therapy for rheumatoid arthritis.
    • Early recognition and intervention with corticosteroids, such as prednisone, can lead to favorable outcomes.
    • Physicians should consider drug-induced lung disease in patients on sodium aurothiomalate presenting with respiratory symptoms.